Polyrizon Ltd. (PLRZ)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Polyrizon Ltd.’s names, not what it holds today.
2 published
1 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Mar 25, 2014 | 8,679,484 | Method for removal of toxins from mucosal membranes | Pharmaceuticals | Polyrizon Ltd. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 31, 2024 | 2024/0358741 | MUCOADHESlVE POLYMERS FOR NASAL DRUG DELIVERY | Pharmaceuticals | POLYRIZON LTD. |
| May 29, 2014 | 2014/0147452 | METHOD FOR REMOVAL OF TOXINS FROM MUCOSAL MEMBRANES | Pharmaceuticals | Polyrizon Ltd. |
| Dec 25, 2008 | 2008/0317765 | Method for Removal of Toxins from Mucosal Membranes | Pharmaceuticals | Polyrizon Ltd. · patent 8,679,484 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.